80 related articles for article (PubMed ID: 3373111)
1. Pharmacokinetics of erythropoietin in intact and anephric dogs.
Fu JS; Lertora JJ; Brookins J; Rice JC; Fisher JW
J Lab Clin Med; 1988 Jun; 111(6):669-76. PubMed ID: 3373111
[TBL] [Abstract][Full Text] [Related]
2. A sensitive and specific erythropoietin immunoprecipitation assay: application to pharmacokinetic studies.
Widness JA; Schmidt RL; Veng-Pedersen P; Modi NB; Sawyer ST
J Lab Clin Med; 1992 Mar; 119(3):285-94. PubMed ID: 1311741
[TBL] [Abstract][Full Text] [Related]
3. Comparative pharmacokinetics and distribution of human urinary erythropoietin and recombinant human erythropoietin in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1991 Sep; 41(9):1004-7. PubMed ID: 1796912
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and distribution of recombinant erythropoietin in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1992 Feb; 42(2):174-8. PubMed ID: 1610430
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of flunixin meglumine in dogs.
Hardie EM; Hardee GE; Rawlings CA
Am J Vet Res; 1985 Jan; 46(1):235-7. PubMed ID: 3970431
[TBL] [Abstract][Full Text] [Related]
6. Distribution of recombinant human erythropoietin following multiple intravenous administration and effects of age on the distribution in rats.
Kinoshita H; Ohishi N; Kato M; Tokura S; Okazaki A
Arzneimittelforschung; 1992 Apr; 42(4):579-84. PubMed ID: 1642686
[TBL] [Abstract][Full Text] [Related]
7. A comparison of mass balance, pharmacokinetics and disposition of [14C(U)]- and [125I]recombinant human interleukin-2 in cynomolgus monkeys.
Nadeau RW; Satoh H; Scheide S; Crowl R; Conroy R; Garland WA; Liberato DJ
Drug Metab Dispos; 1995 Sep; 23(9):904-9. PubMed ID: 8565779
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of procainamide hydrochloride in dogs.
Papich MG; Davis LE; Davis CA; McKiernan BC; Brown SA
Am J Vet Res; 1986 Nov; 47(11):2351-8. PubMed ID: 2431636
[TBL] [Abstract][Full Text] [Related]
9. In vivo 125I-erythropoietin pharmacokinetics are unchanged after anesthesia, nephrectomy and hepatectomy in sheep.
Widness JA; Veng-Pedersen P; Schmidt RL; Lowe LS; Kisthard JA; Peters C
J Pharmacol Exp Ther; 1996 Dec; 279(3):1205-10. PubMed ID: 8968342
[TBL] [Abstract][Full Text] [Related]
10. Preparation of iodine labeled recombinant human erythropoietin.
Kinoshita H; Ohishi N; Okazaki A
Arzneimittelforschung; 1991 May; 41(5):568-70. PubMed ID: 1898429
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and distribution of recombinant human erythropoietin in rats with renal dysfunction.
Kinoshita H; Ohishi N; Tokura S; Okazaki A
Arzneimittelforschung; 1992 May; 42(5):682-6. PubMed ID: 1530684
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and haematological parameters of recombinant human erythropoietin after subcutaneous administrations in horses.
Souillard A; Audran M; Bressolle F; Jaussaud P; Gareau R
Biopharm Drug Dispos; 1996 Dec; 17(9):805-15. PubMed ID: 8968532
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of ticarcillin in the dog.
Tilmant L; Brown MP; Gronwall RR
Am J Vet Res; 1985 Feb; 46(2):479-81. PubMed ID: 3922261
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of thiamphenicol in dogs.
Castells G; Intorre L; Franquelo C; Cristòfol C; Pérez B; Martí G; Arboix M
Am J Vet Res; 1998 Nov; 59(11):1473-5. PubMed ID: 9829409
[TBL] [Abstract][Full Text] [Related]
15. Developmental differences in erythropoietin pharmacokinetics: increased clearance and distribution in fetal and neonatal sheep.
Widness JA; Veng-Pedersen P; Modi NB; Schmidt RL; Chestnut DH
J Pharmacol Exp Ther; 1992 Jun; 261(3):977-84. PubMed ID: 1602403
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of single doses of phenobarbital given intravenously and orally to dogs.
Pedersoli WM; Wike JS; Ravis WR
Am J Vet Res; 1987 Apr; 48(4):679-83. PubMed ID: 3592366
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
Timchalk C; Nolan RJ
Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
[TBL] [Abstract][Full Text] [Related]
18. Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin.
Jolling K; Perez Ruixo JJ; Hemeryck A; Vermeulen A; Greway T
Eur J Pharm Sci; 2005 Apr; 24(5):465-75. PubMed ID: 15784336
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of gentamicin in the juvenile dog.
Riviere JE; Coppoc GL
Am J Vet Res; 1981 Sep; 42(9):1621-3. PubMed ID: 7325472
[TBL] [Abstract][Full Text] [Related]
20. Changes in erythropoietin pharmacokinetics following busulfan-induced bone marrow ablation in sheep: evidence for bone marrow as a major erythropoietin elimination pathway.
Chapel S; Veng-Pedersen P; Hohl RJ; Schmidt RL; McGuire EM; Widness JA
J Pharmacol Exp Ther; 2001 Aug; 298(2):820-4. PubMed ID: 11454947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
